MDR Shigella - Scoping survey for public health laboratories

Closed 21 Jan 2022

Opened 30 Nov 2021

Results expected 9 Feb 2022

Overview

This survey seeks to understand how Shigella is being tested for in Australian public health laboratories, and how antibiotic susceptibility testing for multi-drug resistant Shigella is being reported from reference laboratories to public health authorities. 

The following questions will be used to analyse the testing and reporting processes for MDR Shigella of each jurisdiction. The information provided as part of this survey will be identifiable at the jurisdictional level and will be used by the Public Health Laboratory Network (PHLN) Secretariat and PHLN Expert Reference Panel on Antimicrobial Resistance to develop national recommendations for the surveillance of MDR Shigella in Australia. Please contact the PHLN Secretariat should you have any concerns regarding the use information provided as part of this survey. 

Should you have any supplementary information you wish to provide as part of your response, please email PHLN.Secretariat@health.gov.au 

Please feel free to contact the PHLN Secretariat on 0262895059 should you require any assistance completing this survey. 

Audiences

  • Health professionals

Interests

  • Communicable diseases